About
Advisor to Lightstone Ventures and founder, President and CEO of Calithera Biosciences and Proteolix (acquired by Onyx Pharmaceuticals in 2009). Susan brings extensive operational experience building successful biotech companies with deep expertise in drug discovery and development.
Colleagues at Lightstone Ventures
Caroline Gaynor
Partner at Lightstone Ventures
Christina Isacson
Partner at Lightstone Ventures
Christina Isacson, Ph.D.
Partner at Lightstone Ventures
Doug Treco
Advisor at Lightstone Ventures
Doug Treco, Ph.D.
Advisor at Lightstone Ventures
Frank D. Lee
Advisor at Lightstone Ventures
H. Martin Seidel
Advisor at Lightstone Ventures
H. Martin Seidel, Ph.D.
Advisor at Lightstone Ventures
Frequently asked questions
- Who is Susan Molineaux, Ph.D.?
- Advisor to Lightstone Ventures and founder, President and CEO of Calithera Biosciences and Proteolix (acquired by Onyx Pharmaceuticals in 2009). Susan brings extensive operational experience building successful biotech companies with deep expertise in drug discovery and development.
- Where does Susan Molineaux, Ph.D. work?
- Susan Molineaux, Ph.D. is Advisor at Lightstone Ventures.